Scientists reported the long-term success of an experimental operation in 2015 to transplant skin from genetically modified stem cells to a child with epidermolysis bullosa (EB). For the first time, a team of therapists from Germany and Italy could save a patient whose skin surface had been destroyed by 80%. However, doctors were unsure if the treatment would be successful in the long term and if the skin would remain stable.
Scientists have found that hematopoietic stem cells (HSCs), involved in the immune response, use body fat stores to fight infection. The study could help develop new treatments for diseases in people with weakened immune systems.
US scientists, who created the world’s first living robots, called xenobots, say that a new form of life can now reproduce itself in a way that has not previously been observed in plants or animals.
In a new study, scientists at the University of Illinois Chicago (UIC) have maximized the production of extracellular vesicles by simply changing the way donor mesenchymal stem cells (MSC) are cultured. This method opens up new possibilities for research in cell therapy using transplantation of stem cells or immune cells obtained from patients or donors.
Mesenchymal stem cell therapy has helped reduce mortality, the number of heart attacks, and strokes among patients suffering from chronic NYHA functional class II and III heart failure with reduced ejection fraction.
A study by scientists from Cornell University, US, showed that the antimicrobial properties of some proteins produced by mesenchymal stem cells (MSCs) could be used to develop potential treatments for infected wounds.
A new study by Kyoto University scientists has demonstrated the ability to produce some of the most potent anti-cancer immune cells for adoptive cell therapy (ACT) using induced pluripotent stem cell (iPSC) technology.
A new study of photoreceptor precursors derived from induced pluripotent stem cells (iPSCs) has demonstrated their safety and therapeutic potential as a source of replacement for damaged cells for future clinical trials.
Scientists from the UNESCO International Society on Aging and Disease (ISOAD) have found that mesenchymal stem cells (MSCs) effectively modulate multiple mechanisms in the human body and restore immune homeostasis in COVID-19 patients.
Mesenchymal stem cells (MSCs) have tremendous potential in regenerative medicine, the goal of which is to repair damaged tissues. However, until now, not much has been known about their in vivo plasticity.
Researchers at the University of Tsukuba, Japan, have found a subpopulation of MSCs that promote bone fracture regeneration and exhibit an increased ability to differentiate into various cell types.
Stem cell therapy
- The combination of gene therapy and stem cell therapy has shown long-term success in treating rare skin disease30.12.2021 - 01:34
- Stem cells use fat to fight infection18.12.2021 - 01:04
- Xenobots created a year ago from stem cells have learned to reproduce12.12.2021 - 00:41
- The therapeutic potential of mesenchymal stem cell vesicles could be increased tenfold05.12.2021 - 21:06
Clinic in Kyiv:
+380 67 549 11 61
+380 97 409 91 01
Our representative in Italy:
+99 559 761 43 34
+99 559 996 15 15
Clinic in Prague:
+420 720 087 788
+420 720 097 788